TGFB1 and hepatocellular carcinoma: Hep3B cell line, which is derived from human hepatocellular carcinoma cells, has been reported to be sensitive to TGFβ1, and the cell growth of Hep3B was inhibited by treatment with TGFβ1 [20, 25- 27].